N-Acetyloxytocin is an oxytocin derivative with an N-terminal acetyl group influencing polarity and hydrogen-bond accessibility. Researchers use it to study modified folding, receptor-contact surfaces, and conformational transitions. The peptide's structure supports high-resolution biophysical assays.
CAT No: R2297
CAS No:10551-48-1
Synonyms/Alias:N-Acetyloxytocin;10551-48-1;Oxytocin, N-acetyl-;N(alpha)-Acetyloxytocin;(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-acetamido-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide;N-Acetyl Oxystin;SCHEMBL16790726;HY-P3219;CS-0169709;N-Acetyl Oxystin; Oxytocin Imp. E (EP): N-Acetyloxytocin; Oxytocin, N-acetyl- (8CI, 9CI, ACI); 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv. (ZCI); Oxytocin, 1-(N-acetylcysteine) (7CI);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.